Atezolizumab Plus Cobimetinib Improves Cancer Control for Patients with Biliary Tract Cancer

A phase II study presented at AACR found that the combination of atezolizumab plus cobimetinib improved cancer control in some patients with biliary tract cancer.

Source: CancerNetwork - May 13, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news